Functional and structural characterization of a β-glucosidase involved in saponin metabolism from intestinal bacteria

Ekor, 2014, The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety, Front. Pharmacol., 4, 177, 10.3389/fphar.2013.00177 Li, 2017, Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?, AM. J. Cancer. Res., 7, 2350 Slezakova, 2017, Anticancer activity of artemisinin and its derivatives, Anticancer Res., 37, 5995 Zang, 2017, Application of magnetically immobilized edible fungus for the biotransformation of panax notoginseng saponin Rb1 to Rd and Rg3, J. Chrom. B Analyt. Technol. Biomed. Life Sci., 1061–1062, 306, 10.1016/j.jchromb.2017.07.038 Xu, 2017, Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota, Med. Res. Rev., 37, 1140, 10.1002/med.21431 Vincken, 2007, Saponins, classification and occurrence in the plant kingdom, Phytochemistry, 38, 275, 10.1016/j.phytochem.2006.10.008 Sun, 2015, Neuroprotection by saponins, Phytother Res., 29, 187, 10.1002/ptr.5246 Tong, 2012, Cytotoxicity and apoptosis-inducing effect of steroidal saponins from Dioscorea zingiberensis Wright against cancer cells, Steroids, 77, 1219, 10.1016/j.steroids.2012.04.019 Du, 2005, Eimeria tenella: ginsenosides-enhanced immune response to the immunization with recombinant 5401 antigen in chickens, Exp. Parasitol., 111, 191, 10.1016/j.exppara.2005.07.006 Chung, 2016, Methyl protodioscin, a steroidal saponin, inhibits neointima formation in vitro and in vivo, J. Nat. Prod., 79, 1635, 10.1021/acs.jnatprod.6b00217 Crow, 2011, Microbiome: that healthy gut feeling, Nature, 480, S88, 10.1038/480S88a An, 2016, Gut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb 1 in rats: contrary effects of antimicrobials treatment and restraint stress, Chem. Biol. Interact., 258, 187, 10.1016/j.cbi.2016.09.005 Bae, 2000, Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria, Biol. Pharm. Bull., 23, 1481, 10.1248/bpb.23.1481 Minor, 2006, HKL-3000: the integration of data reduction and structure solution–from diffraction images to an initial model in minutes, Acta Crystallogr., 62, 859 Mccoy, 2007, Phaser crystallographic software, J. Appl. Crystallogr., 40, 658, 10.1107/S0021889807021206 Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr., 60, 2126 Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr., 66, 213 McAndrew, 2013, From soil to structure, a novel dimeric β-glucosidase belonging to glycoside hydrolase family 3 isolated from compost using metagenomic analysis, J. Biol. Chem., 288, 14985, 10.1074/jbc.M113.458356 Wohlers, 2012, CSA: comprehensive comparison of pairwise protein structure alignments, Nucleic Acids Res., 40, 10.1093/nar/gks362 Hemsworth, 2016, Structural dissection of a complex Bacteroides ovatus gene locus conferring xyloglucan metabolism in the human gut, Open Biol., 6, 160142, 10.1098/rsob.160142 Nakajima, 2016, Functional and structural analysis of a beta-glucosidase involved in beta-1,2-glucan metabolism in Listeria innocua, PLoS One, 11, 10.1371/journal.pone.0148870 Hong, 2012, Enzymatic biotransformation of ginsenoside Rb1 and gypenoside XVII into ginsenosides Rd and F2 by recombinant β-glucosidase from Flavobacterium johnsoniae, J Ginseng. Res., 36, 418, 10.5142/jgr.2012.36.4.418 Chi, 2005, Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms, Biotechnol. Lett., 27, 765, 10.1007/s10529-005-5632-y Tsai, 2009, The microbiome and obesity: is obesity linked to our gut flora?, Curr. Gastroenterol. Rep., 11, 307, 10.1007/s11894-009-0045-z El, 2013, The abundance and variety of carbohydrate-active enzymes in the human gut microbiota, Nat. Rev. Microbiol., 11, 497, 10.1038/nrmicro3050 Kobashi, 1997, Relation of intestinal bacteria to pharmacological effects of glycosides, Bio. Microb. Food & Health, 16, 1 Kim, 2013, Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K, PLoS One, 8 Picard, 2005, Review article: bifidobacteria as probiotic agents-physiological effects and clinical benefits, Aliment. Pharmacol. Ther., 22, 495, 10.1111/j.1365-2036.2005.02615.x Fukuda, 2011, Bifidobacteria can protect from enteropathogenic infection through production of acetate, Nature, 469, 543, 10.1038/nature09646 Jung, 2012, Metabolism of ginsenoside Rb1 by human intestinal microflora and cloning of its metabolizing beta-D-glucosidase from Bifidobacterium longum H-1, Biol. Pharm. Bull., 35, 573, 10.1248/bpb.35.573 Jia, 2008, Gut microbiota: a potential new territory for drug targeting, Nat. Rev. Drug Discov., 7, 123, 10.1038/nrd2505